| P50 | author | John Thyfault | Q37837332 |
| | Ryan D Sheldon | Q57344169 |
| | Justin A Fletcher | Q63897387 |
| | R Scott Rector | Q75438426 |
| | E Matthew Morris | Q80283138 |
| | Melissa A Linden | Q80352720 |
| | Grace M E Meers | Q114314682 |
| | James W Perfield | Q114314683 |
| P2093 | author name string | Anthony Butterfield | |
| P2860 | cites work | FGF-21 as a novel metabolic regulator | Q24523933 |
| | Integrated regulation of hepatic metabolism by fibroblast growth factor 21 (FGF21) in vivo | Q24632545 |
| | Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver | Q24647278 |
| | FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response | Q24653481 |
| | Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1 | Q28131760 |
| | Reduced expression of PGC-1 and insulin-signaling molecules in adipose tissue is associated with insulin resistance | Q28207189 |
| | Transcriptional coactivator PGC-1alpha integrates the mammalian clock and energy metabolism | Q28508765 |
| | Changes in skeletal muscle mitochondria in response to the development of type 2 diabetes or prevention by daily wheel running in hyperphagic OLETF rats | Q28580733 |
| | Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states | Q29615208 |
| | CREB regulates hepatic gluconeogenesis through the coactivator PGC-1 | Q29615692 |
| | Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats | Q33930333 |
| | Intrinsic aerobic capacity impacts susceptibility to acute high-fat diet-induced hepatic steatosis | Q34062800 |
| | FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. | Q34315567 |
| | New methods for calculating metabolic rate with special reference to protein metabolism | Q34351677 |
| | Increased mitochondrial mass in mitochondrial myopathy mice | Q34381144 |
| | Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. | Q34428501 |
| | Diminished hepatic gluconeogenesis via defects in tricarboxylic acid cycle flux in peroxisome proliferator-activated receptor gamma coactivator-1alpha (PGC-1alpha)-deficient mice | Q34617976 |
| | Hepatic lipin 1beta expression is diminished in insulin-resistant obese subjects and is reactivated by marked weight loss | Q34636634 |
| | Acute exercise induces FGF21 expression in mice and in healthy humans | Q34718217 |
| | Fibroblast growth factor 21 corrects obesity in mice | Q34805555 |
| | Female rats selectively bred for high intrinsic aerobic fitness are protected from ovariectomy-associated metabolic dysfunction | Q35178702 |
| | PGC-1α overexpression results in increased hepatic fatty acid oxidation with reduced triacylglycerol accumulation and secretion. | Q36312713 |
| | FGF21 Mediates Endocrine Control of Simple Sugar Intake and Sweet Taste Preference by the Liver | Q36588765 |
| | An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice | Q36886578 |
| | Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations. | Q36976053 |
| | Metabolic Responses to Dietary Protein Restriction Require an Increase in FGF21 that Is Delayed by the Absence of GCN2 | Q37116027 |
| | Sensitivity of lipid metabolism and insulin signaling to genetic alterations in hepatic peroxisome proliferator-activated receptor-gamma coactivator-1alpha expression | Q37236343 |
| | Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity | Q37328872 |
| | Fibroblast growth factor 21: an overview from a clinical perspective | Q37412337 |
| | Interplay between FGF21 and insulin action in the liver regulates metabolism | Q37524205 |
| | Peroxisome proliferator activator receptor gamma coactivator-1 expression is reduced in obesity: potential pathogenic role of saturated fatty acids and p38 mitogen-activated protein kinase activation | Q38302923 |
| | Fibroblast growth factor 21 reverses suppression of adiponectin expression via inhibiting endoplasmic reticulum stress in adipose tissue of obese mice | Q38733095 |
| | Mitochondria-related transcriptional signature is downregulated in adipocytes in obesity: a study of young healthy MZ twins. | Q39297379 |
| | Voluntary Running Attenuates Metabolic Dysfunction in Ovariectomized Low-Fit Rats | Q39350536 |
| | Discrete Aspects of FGF21 In Vivo Pharmacology Do Not Require UCP1. | Q40958865 |
| | Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis. | Q41630408 |
| | The breadth of FGF21's metabolic actions are governed by FGFR1 in adipose tissue | Q41912342 |
| | The role of PGC-1alpha on mitochondrial function and apoptotic susceptibility in muscle | Q42453678 |
| | Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice | Q43224118 |
| | The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man. | Q46445480 |
| | Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka Long-Evans Tokushima Fatty rats. | Q46823988 |
| | Long-acting FGF21 has enhanced efficacy in diet-induced obese mice and in obese rhesus monkeys | Q46844955 |
| | FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting | Q48659709 |
| | Role of PGC-1α in exercise and fasting-induced adaptations in mouse liver. | Q51369626 |
| | FGF21: a missing link in the biology of fasting. | Q51470091 |
| | Dual effects of fibroblast growth factor 21 on hepatic energy metabolism. | Q51741443 |
| | Pharmacologic Effects of FGF21 Are Independent of the "Browning" of White Adipose Tissue. | Q53514538 |
| | Biomarkers of mitochondrial content in skeletal muscle of healthy young human subjects | Q58456009 |
| | Energy cost of gluconeogenesis in rat liver | Q68750160 |
| | Exercise-induced rise in glucagon and ketogenesis during prolonged muscular work | Q69370044 |
| | The effects of acute and chronic exercise on PGC-1α, irisin and browning of subcutaneous adipose tissue in humans | Q86752708 |
| P433 | issue | 3 | |
| P304 | page(s) | 408-418 | |
| P577 | publication date | 2018-01-16 | |
| P1433 | published in | Experimental Physiology | Q1091760 |
| P1476 | title | Fibroblast growth factor 21 increases hepatic oxidative capacity but not physical activity or energy expenditure in hepatic peroxisome proliferator-activated receptor γ coactivator-1α-deficient mice | |
| P478 | volume | 103 | |